Related Experiment Video
Updated: Jul 11, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Utility of Film Array Meningoencephalitis Panel in Children With Acute Encephalitis Syndrome: A Single Centre
Dona Teresa Thomas1, P A Kunju Mohammed2, Greeshma Baby2
1Department of Pediatric Neurology, Kerala Institute of Medical Sciences, Trivandrum, Kerala, India. Correspondence to: Dr. Dona Teresa Thomas, Senior Resident, Department of Pediatric Neurology, Kerala Institute of Medical Sciences, Trivandrum, Kerala, India. donsteresa34@gmail.com.
Insights
The Film Array Meningoencephalitis (FAME) panel rapidly identifies pathogens in children with acute encephalitis syndrome (AES), aiding in reduced empirical antibiotic and antiviral therapy.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Neuroscience
Background:
- Acute Encephalitis Syndrome (AES) poses a significant diagnostic challenge in pediatric populations.
- Timely and accurate etiological diagnosis is crucial for effective management and improved patient outcomes.
Purpose of the Study:
- To evaluate the clinical utility of the Film Array Meningoencephalitis (FAME) panel in diagnosing pediatric AES.
- To assess the impact of FAME panel results on empirical antimicrobial and antiviral treatment strategies.
Main Methods:
- A retrospective audit of pediatric patients diagnosed with AES was conducted.
- Cerebrospinal fluid (CSF) samples were analyzed using the FAME panel within 48 hours of admission.
- Patient electronic medical records were reviewed for clinical data, investigations, and outcomes.
Main Results:
- The FAME panel identified the etiology in 31.4% of tested CSF samples.
- Viral pathogens were the most common (e.g., Enterovirus, HHV-6), followed by bacterial and fungal agents.
- Establishment of a specific etiology allowed for de-escalation of empirical antibiotic and antiviral therapies in a significant proportion of children.
Conclusions:
- The FAME panel is an effective tool for rapid etiological diagnosis in pediatric AES.
- Utilizing the FAME panel can lead to a reduction in the duration of empirical antibiotic and antiviral treatments, optimizing patient care.
Objective:
To describe the utility of film array meningoencephalitis (FAME) panel in the management of children with acute encephalitis syndrome (AES).
Methods:
A retrospective audit was conducted between January 2017 to July 2022. We included children aged < 18 years with a diagnosis of AES for whom a CSF analysis study including FAME panel testing performed within 48 hours of admission was available. Electronic medical records were reviewed for details including demographic profile, clinical presentation, investigations and outcome.
Results:
Out of 157 CSF samples sent for FAME panel testing, 49 were positive (31.4%.) Viral pathogens were identified in 42 (Enterovirus: 31, Human herpes virus 6: 9, Varicella zoster virus: 1, and Cytomegalovirus: 1) Bacterial pathogens were identified in 6 (Streptococcus pneumoniae: 2, Streptococcus agalactiae: 2, Hemophilus influenzae: 1, and Escherischia coli: 1). Fungal etiology (Cryptococcus neoformans) was detected in one child. Antibiotics could be stopped within 72 hours of initiation in 42 children in whom a viral etiology was established. Acyclovir could be stopped in 21 out of 32 children within 72 hours after the FAME panel testing. FAME panel was presumed to be false positive in 4 children.
Conclusion:
Etiology of AES could be established in nearly a third of children with AES using the rapid diagnostic FAME panel testing in CSF and it was found to be effective in reducing empirical antibiotic/antiviral therapy.
More Related Videos
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

